Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Yuan Fang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1931-2632; OpenAlex author ID A5101879196. Sources: OpenAlex.

Their work

Papers
14 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 2 papers · 2018: none · 2019: 3 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 14

  1. GALNT5 promotes migration and invasion of pancreatic ductal adenocarcinoma cells by activating Erk signaling pathway. Co-author DOI 10.1016/j.bbagen.2025.130769↗
  2. Cancer-Associated Fibroblast-Derived Exosomal miRNA-320a Promotes Macrophage M2 Polarization In Vitro by Regulating PTEN/PI3Kγ Signaling in Pancreatic Cancer. Last author DOI 10.1155/2022/9514697↗
  3. Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis. First author DOI 10.1080/15384101.2021.1874684↗
  4. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis. Co-author DOI 10.1007/s13402-019-00435-1↗
  5. HEATR1 Deficiency Promotes Chemoresistance via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer. Co-author DOI 10.1155/2020/3181596↗
  6. TRAF6 regulates YAP signaling by promoting the ubiquitination and degradation of MST1 in pancreatic cancer. Co-author DOI 10.1007/s10238-018-00543-6↗
  7. Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway. Co-author DOI 10.1016/j.canlet.2019.06.013↗
  8. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1016/j.yexcr.2019.111543↗
  9. BRSK2 induced by nutrient deprivation promotes Akt activity in pancreatic cancer via downregulation of mTOR activity. Co-author DOI 10.18632/oncotarget.17965↗
  10. Moscatilin induces apoptosis of pancreatic cancer cells via reactive oxygen species and the JNK/SAPK pathway. First author DOI 10.3892/mmr.2017.6144↗
  11. IL-8-Positive Tumor-Infiltrating Inflammatory Cells Are a Novel Prognostic Marker in Pancreatic Ductal Adenocarcinoma Patients. Co-author DOI 10.1097/mpa.0000000000000520↗
  12. HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy. First author DOI 10.1158/0008-5472.can-15-0671↗
  13. Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/path.4506↗
  14. [Expression of dihydropyrimidine dehydrogenase negatively correlated with the prognosis of pancreatic ductal adenocarcinoma]. Co-author PMID 21612699↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xu Han · 6 shared papers, 2015–2021 · strength 0.56
  2. Wenhui Lou · 6 shared papers, 2011–2021 · strength 0.55
  3. Yefei Rong · 5 shared papers, 2019–2021 · strength 0.52
  4. Jianang Li · 4 shared papers, 2019–2021 · strength 0.48
  5. Tiantao Kuang · 4 shared papers, 2019–2020 · strength 0.42
  6. Shengjun Wang · 1 shared paper, 2025 · strength 0.30
  7. Yongjia Zheng · 1 shared paper, 2025 · strength 0.30
  8. Xuefeng Xu · 3 shared papers, 2019 · strength 0.27
  9. Dansong Wang · 3 shared papers, 2019 · strength 0.27
  10. Wenchuan Wu · 3 shared papers, 2019 · strength 0.27
  11. Mingkun Zhao · 1 shared paper, 2022 · strength 0.26
  12. Wentao Zhou · 2 shared papers, 2019–2021 · strength 0.23
  13. Hexige Saiyin · 3 shared papers, 2015–2017 · strength 0.19
  14. Dayong Jin · 2 shared papers, 2017–2019 · strength 0.18
  15. Ning Pu · 2 shared papers, 2019 · strength 0.17
  16. Wenhui Lou · 3 shared papers, 2015–2016 · strength 0.16
  17. Wenhui Lou · 1 shared paper, 2020 · strength 0.15
  18. Yaolin Xu · 1 shared paper, 2021 · strength 0.13
  19. Mengmeng Liu · 1 shared paper, 2020 · strength 0.11
  20. Chao Song · 1 shared paper, 2020 · strength 0.11
  21. Lei Zhang · 1 shared paper, 2017 · strength 0.10
  22. Jian-ang Li · 1 shared paper, 2019 · strength 0.08
  23. Hanlin Yin · 1 shared paper, 2019 · strength 0.08
  24. Shanshan Gao · 1 shared paper, 2019 · strength 0.08
  25. Wenhui Lou · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.